Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 USD | +1.74% |
|
+1.74% | -61.70% |
Jun. 27 | GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650 | MT |
Jun. 27 | GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-61.70% | 6.32M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- GTBP Stock
- News GT Biopharma, Inc.
- HC Wainwright Adjusts Price Target on GT Biopharma to $5 From $25, Reiterates Buy Rating